Skip to main content
Premium Trial:

Request an Annual Quote

SEC Gives Green Light for Pharmacopeia Spin-off

NEW YORK, April 20 (GenomeWeb News) - The SEC has declared the registration statement on Form 10 of Pharmacopeia Drug Discovery effective, thus clearing the way for PDD's spin-off to Pharmacopeia stockholders, Pharmacopeia said yesterday.

 

PDD common stock was expected to begin trading on a "when issued" basis on the Nasdaq National Market today under the ticker symbol "PCOPV".

 

Pharmacopeia announced its intention to spin off its drug discovery unit in December.